We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Pharmacovigilance Notification Requirements Are Now In Effect
EU Pharmacovigilance Notification Requirements Are Now In Effect
For the first time brand and generic drugmakers are required to notify the EMA and individual country regulators when they withdraw a drug from the market anywhere in the EU, and the reasons why, to comply with the EU’s newly amended pharmacovigilance law.